Int J Heart Fail.
2023 Apr;5(2):106-110. 10.36628/ijhf.2022.0034.
The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and MetaAnalysis
- Affiliations
-
- 1Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA
- 2Center for Clinical Epidemiology and Clinical Statistics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
- 3Department of Family Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
- 4Division of Nephrology & Hypertension, Mayo Clinic, Rochester, MN, USA
- 5Department of Cardiology, Texas Tech University Health Sciences Center, Lubbock, TX, USA
- KMID: 2547676
- DOI: http://doi.org/10.36628/ijhf.2022.0034
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Does Milrinone Improve Hemodynamic Variables in Patients with Pulmonary Hypertension Due to Valvular Heart Disease?
- Hemodynamics of Milrinone and Low-Dose Vasopressin Infusion during OPCAB
- Experience of Milrinone Treatment for Persistent Pulmonary Hypertension of the Newborn
- Anesthetic management of cesarean delivery of parturient with systemic lupus erythematosus associated with pulmonary arterial hypertension - A case report -
- Safety and Efficacy of the Off-Label Use of Milrinone in Pediatric Patients with Heart Diseases
